Close Ham Menu
1200 Summit Avenue, Suite 414 Fort Worth, TX 76102
(817) 529-2300
Neep Help? Email us at [email protected]
Search
Ham Menu

BIAKŌS™ ANTIMICROBIAL SKIN & WOUND CLEANSER

BIAKŌS™ ANTIMICROBIAL SKIN & WOUND CLEANSER works synergistically to cleanse and remove microbes from the wound bed to help eliminate planktonic, immature and mature biofilms.

Buy Now Sales Brochure Product Insert
BIAKOS™ Antimicrobial Skin & Wound Cleanser

BIAKŌS™ Works Synergistically

The patented technology and ingredients in BIAKŌS™ work to:

Eliminate...

Planktonic, immature and mature biofilms.

Attack...

Gram-negative bacteria, Gram-positive bacteria, fungi, viruses and spores

Support...

Normal wound-healing pH.

Remove...

Odor producing microbes.

Create...

A safe environment conducive to wound healing.

BIAKOS Works Synergistically

Safely Disrupt Biofilm Microbes

BIAKŌS™ ANTIMICROBIAL SKIN & WOUND CLEANSER is intended for mechanical cleansing and removal of debris, dirt and foreign materials, including microorganisms, from wounds. Such as:

• Stage I-IV Pressure Ulcers • First- and second-degree burns • Diabetic foot ulcers • Grafted and donor sites • Post-surgical wounds
Safely Disrupt Biofilm

Ingredients in BIAKŌS™ ANTIMICROBIAL SKIN & WOUND CLEANSER

*PHMB

Poloxamer 407

Ingredients in BIAKOS Antimicrobial Skin & Wound Cleanser
*Synergistic Ingedients

*Vicinal Diols

*EDTAs

Learn More about the Synergistic Ingredients

BIAKŌS™ Is Effective Against*

Gram-positive bacteria

Gram-positive bacteria

Clostridium difficile

Enterococcus faecalis

Methicillin Resistant Staphylococcus aureus (MRSA)

Staphylococcus aureus

Staphylococcus epidermidis

Vancomycin Resistant Enterococcus faecalis (VREF)

Gram-negative bacteria

Gram-negative bacteria

Acinetobacter baumannii

Carbapenum Resistant Escherichia coli (CRE)

Enterobacter cloacae

Escherichia coli

Klebsiella pneumoniae

Proteus mirabilis

Pseudomonas aeruginosa

Serratia marcescens

Fungi

Fungi

Candida albicans

Candida auris

Trichosporin asahii

Viruses

Viruses

Human Coronavirus

SARS‐CoV‐2

Spores

Spores

Bacillus cereus

Clostridium difficile

*Kill rate testing in solution; Data on file

Contact Sanara MedTech

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Doctor

Keep Up With the Latest Developments
in Surgical and Wound Care Technology

Sign Up for the Sanara MedTech Mailing List

Most Recent Press Releases

Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

March 12, 2025

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

January 22, 2025

Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments

January 22, 2025
All Press Releases
Logo

© 2025 All Rights Reserved. Sanara MedTech Inc.

Privacy Policy Terms of Use